SPL

What SPL does

Surgical Pathology Laboratories (SPL) is a privately held professional association (P.A.) founded in 1998 by Dr. Jeffrey Bulson in Pinellas Park, Florida. The company provides specialized surgical pathology diagnostic services — primarily frozen section analysis for intraoperative tumor diagnosis and margin evaluation, plus dermatopathology, orthopedic pathology, gynecologic pathology, and biopsy interpretation — to solo medical practices, group practices, Mohs surgeons, dermatologists, plastic surgeons, and surgical centers throughout Florida. SPL operates through two distribution channels: a fleet of CLIA and Florida-licensed mobile laboratory units that deploy on-site to client locations, and a CAP-accredited central laboratory in Pinellas Park equipped with LEICA RM2255 instrumentation.

The core technology is the frozen section technique, supported by proprietary peripheral/breadloaf-cross margin evaluation (claimed to view 99% of margin surface), triple immunostaining for angiolymphatic/perineural invasion, and on-site cytohistologic study. These methods enable diagnosis and signed reporting within minutes of lesion removal at the point of care. Staff includes 7 board-certified pathologists with subspecialty expertise (including a former Mayo Clinic Florida Director of Dermatopathology) supported by 9 full-time histotechnologists. The practice holds CAP accreditation, CLIA certification, and Florida licensure, and is HIPAA-compliant.

SPL's revenue model is professional services billing for pathology diagnostics, with claims submitted to all insurance carriers and in-house appeals management. Pricing is per-service and not publicly disclosed; the company provides Good Faith Estimates as required by law. Marketing is primarily through professional referrals and reputation. SPL claims to be Florida's largest provider of frozen section coverage to individual doctors, group practices, and surgical centers — a position built over 27 years of operation in a single state with no external investment, M&A activity, or geographic expansion disclosed.

Name

SPL

Legal name

Surgical Pathology Laboratories, P.A.

Website

https://surgicalpathlabs.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Surgical Pathology Laboratories is a Florida-based private pathology practice providing frozen section intraoperative diagnosis and margin evaluation, plus dermatopathology, orthopedic, gynecologic, and biopsy services to medical practices and surgical centers via mobile laboratories and a central Pinellas Park lab.

Ownership category

akta.pro rank

Product category

Pathology Diagnostic Services

NAICS

Outpatient Care Centers (6214)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Point-of-Care Testing (POCT) & Near-Patient Labs (HLAFAMAI)

Keywords

• Frozen section pathology
• Pathology diagnostic services
• Dermatopathology diagnostics
• Mobile pathology services
• Margin evaluation services

Headquarters

HQ city

Pinellas Park

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Revenue model

1. Pathology Diagnostic Services: SPL generates revenue through professional pathology diagnostic services billed to healthcare providers, surgical centers, and insurance carriers. Services include frozen section analysis, margin evaluation, and comprehensive biopsy evaluation. The company submits claims to all insurance carriers and manages the appeals process for denied claims.
2. Mobile Laboratory Services: On-site pathology services provided at client medical practices and surgical centers using mobile laboratory units. Revenue generated through service fees for on-site frozen section diagnosis and margin evaluation with same-day reporting.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels1 record

Core offering

SPL provides intraoperative frozen section pathology services, delivering rapid tumor diagnosis and surgical margin evaluation directly to medical practices and ambulatory surgical centers via mobile laboratory units throughout Florida. The service enables surgeons to receive pathology results during the procedure itself, supporting real-time clinical decisions on tumor resection and clearance.

Differentiator

Problem solved

Functional benefit

Products and services

• Frozen Section Services

Quantifiable outcome

• Immediate diagnosis and signed reports at time of service
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• PathGroup: One of the largest U.S. independent pathology groups, offering anatomic and clinical pathology services across multiple states. Directly comparable to SPL as a specialty-focused pathology practice serving surgeons, dermatologists, and outpatient providers.
• ProPath: Specialty pathology practice with strong dermatopathology and surgical pathology focus. Comparable to SPL's subspecialty bench and focus on serving dermatologists, Mohs surgeons, and outpatient surgical practices.
• Inform Diagnostics: Specialty pathology provider with a dermatopathology and gastrointestinal pathology emphasis. Closely matches SPL's subspecialty mix and outpatient physician customer base.
• Aurora Diagnostics: Multi-specialty anatomic pathology group serving community hospitals and outpatient practices. Comparable to SPL in surgical pathology services and physician-office customer base, though at larger scale.
• CBLPath: Specialty pathology laboratory focused on dermatopathology, hematopathology, and molecular diagnostics. Overlaps with SPL's dermatopathology and oncology case mix serving outpatient practices.

Broad incumbents

• Sonic Healthcare USA: Global diagnostics provider with significant U.S. anatomic pathology presence (including former Aurora Diagnostics assets). Competes broadly with SPL across surgical pathology but does not focus on Florida mobile frozen-section services.
• Quest Diagnostics: Largest U.S. clinical reference laboratory offering broad anatomic and clinical pathology services. Overlaps with SPL on dermatopathology and biopsy interpretation but is not focused on mobile intraoperative frozen-section services.
• Laboratory Corporation of America (Labcorp): Major U.S. reference laboratory offering comprehensive anatomic pathology and dermatopathology services. Comparable as a broad pathology competitor but lacks SPL's mobile frozen-section distribution model.
• ARUP Laboratories: Academic-affiliated national reference laboratory with deep subspecialty pathology expertise. Comparable to SPL in subspecialty depth but serves different customers (primarily hospital systems) via a centralized lab model.

Emerging players

• NeoGenomics: Specialty oncology-focused laboratory with growing anatomic pathology and molecular services. Comparable in oncology case focus and subspecialty positioning to SPL's cancer diagnostic work, though oriented more toward molecular oncology.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/102962723103360

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SPL